Vijaya Diagnostic Centre Limited (BOM:543350)
India · Delayed Price · Currency is INR 988.05
-7.40 (-0.74%)
At close: Feb 13, 2026
Vijaya Diagnostic Centre Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 7,737 | 6,814 | 5,478 | 4,592 | 4,624 | 3,767 |
Revenue Growth (YoY) | 16.63% | 24.39% | 19.29% | -0.68% | 22.73% | 11.19% |
Cost of Revenue | 1,153 | 1,081 | 863.73 | 764.66 | 847.93 | 673.34 |
Gross Profit | 6,584 | 5,733 | 4,614 | 3,828 | 3,776 | 3,094 |
Selling, General & Admin | 1,367 | 1,235 | 985.79 | 846.63 | 758.93 | 612.4 |
Other Operating Expenses | 2,059 | 1,766 | 1,420 | 1,161 | 979.87 | 818.65 |
Operating Expenses | 4,288 | 3,707 | 2,975 | 2,624 | 2,266 | 1,939 |
Operating Income | 2,296 | 2,026 | 1,639 | 1,203 | 1,510 | 1,155 |
Interest Expense | -289 | -245.46 | -219.62 | -194.25 | -152.15 | -135.09 |
Interest & Investment Income | 57.63 | 57.63 | 59.73 | 82.8 | 97.99 | 95.96 |
Other Non Operating Income (Expenses) | -19.65 | -19.65 | -16.65 | -13.58 | -9.32 | -16.72 |
EBT Excluding Unusual Items | 2,045 | 1,819 | 1,462 | 1,078 | 1,447 | 1,099 |
Gain (Loss) on Sale of Investments | 118.66 | 118.66 | 124.76 | 47.19 | 18.39 | 4.86 |
Gain (Loss) on Sale of Assets | 1.31 | 1.31 | 19.52 | 0.86 | 3.98 | 1.56 |
Other Unusual Items | -7.04 | -7.04 | -19.95 | 9 | 2.14 | 15.44 |
Pretax Income | 2,158 | 1,932 | 1,587 | 1,135 | 1,474 | 1,121 |
Income Tax Expense | 558.69 | 493.71 | 390.44 | 283.03 | 367.17 | 269.97 |
Earnings From Continuing Operations | 1,599 | 1,438 | 1,196 | 852.07 | 1,107 | 851.27 |
Minority Interest in Earnings | -7.18 | -7.18 | -8.12 | -5.75 | -9.87 | -6.48 |
Net Income | 1,592 | 1,431 | 1,188 | 846.32 | 1,097 | 844.78 |
Net Income to Common | 1,592 | 1,431 | 1,188 | 846.32 | 1,097 | 844.78 |
Net Income Growth | 12.20% | 20.41% | 40.40% | -22.84% | 29.83% | 35.08% |
Shares Outstanding (Basic) | 103 | 103 | 102 | 102 | 102 | 102 |
Shares Outstanding (Diluted) | 103 | 103 | 103 | 102 | 103 | 102 |
Shares Change (YoY) | 0.07% | 0.26% | 0.03% | -0.08% | 0.57% | -0.02% |
EPS (Basic) | 15.51 | 13.95 | 11.62 | 8.29 | 10.76 | 8.28 |
EPS (Diluted) | 15.48 | 13.92 | 11.59 | 8.26 | 10.69 | 8.28 |
EPS Growth | 12.11% | 20.10% | 40.31% | -22.73% | 29.11% | 35.07% |
Free Cash Flow | - | 1,289 | 953.37 | 397.69 | 356.5 | 975.06 |
Free Cash Flow Per Share | - | 12.54 | 9.30 | 3.88 | 3.48 | 9.56 |
Dividend Per Share | - | 2.000 | 1.000 | 1.000 | 1.000 | - |
Dividend Growth | - | 100.00% | - | - | - | - |
Gross Margin | 85.10% | 84.14% | 84.23% | 83.35% | 81.66% | 82.13% |
Operating Margin | 29.67% | 29.74% | 29.92% | 26.20% | 32.66% | 30.66% |
Profit Margin | 20.58% | 21.00% | 21.69% | 18.43% | 23.72% | 22.42% |
Free Cash Flow Margin | - | 18.92% | 17.40% | 8.66% | 7.71% | 25.88% |
EBITDA | 2,750 | 2,411 | 1,930 | 1,581 | 1,846 | 1,491 |
EBITDA Margin | 35.55% | 35.38% | 35.23% | 34.44% | 39.92% | 39.57% |
D&A For EBITDA | 454.17 | 384.32 | 291.19 | 378.31 | 335.58 | 335.67 |
EBIT | 2,296 | 2,026 | 1,639 | 1,203 | 1,510 | 1,155 |
EBIT Margin | 29.67% | 29.74% | 29.92% | 26.20% | 32.66% | 30.66% |
Effective Tax Rate | 25.89% | 25.56% | 24.61% | 24.93% | 24.91% | 24.08% |
Revenue as Reported | 7,920 | 6,997 | 5,686 | 4,734 | 4,752 | 3,886 |
Advertising Expenses | - | 24.83 | 35.51 | 23.78 | 29.17 | 17.64 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.